Literature DB >> 1724279

Analysis of Haemophilus influenzae type b lipooligosaccharide-synthesis genes that assemble or expose a 2-keto-3-deoxyoctulosonic acid epitope.

Y Abu Kwaik1, R E McLaughlin, M A Apicella, S M Spinola.   

Abstract

We recently isolated a recombinant phage from a Haemophilus influenzae type b (Hib) library that assembles an oligosaccharide with an apparent molecular weight of 1400 (1.4 K) on a 4.1 K Escherichia coli lipopolysaccharide (LPS) structure, producing a 5.5 K LPS species that contains a KDO (2-keto-deoxyoctulosonic acid) epitope. Subcloning and deletional analysis of the 14 kb Haemophilus insert showed that three overlapping restriction fragments contained within a 7.2 kb Pstl-BamHl fragment sequentially modified an E. coli 4.1 K LPS structure, generating novel species of 4.5 K, 5.1 K and 5.5 K. Only the 5.5 K species contained the KDO epitope. We confirmed the relationship between the cloned genes and Hib lipooligosaccharide (LOS) biosynthesis by constructing a mutant that expressed an altered LOS. Thus, the Hib 7.2 kb Pstl-BamHl restriction fragment contained a cluster of at least three genetic loci whose products acted sequentially in LOS biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1724279     DOI: 10.1111/j.1365-2958.1991.tb02092.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  13 in total

Review 1.  Immunopathogenesis of Haemophilus ducreyi infection (chancroid).

Authors:  Stanley M Spinola; Margaret E Bauer; Robert S Munson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  Inactivation of Haemophilus influenzae lipopolysaccharide biosynthesis genes interferes with outer membrane localization of the hap autotransporter.

Authors:  Nicole A Spahich; Derek W Hood; E Richard Moxon; Joseph W St Geme
Journal:  J Bacteriol       Date:  2012-01-27       Impact factor: 3.490

3.  Biosynthesis of cryptic lipopolysaccharide glycoforms in Haemophilus influenzae involves a mechanism similar to that required for O-antigen synthesis.

Authors:  Derek W Hood; Gaynor Randle; Andrew D Cox; Katherine Makepeace; Jianjun Li; Elke K H Schweda; James C Richards; E Richard Moxon
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

4.  Identification of a new locus involved in expression of Haemophilus influenzae type b lipooligosaccharide.

Authors:  G P Jarosik; E J Hansen
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

Review 5.  Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections.

Authors:  K W Deitsch; E R Moxon; T E Wellems
Journal:  Microbiol Mol Biol Rev       Date:  1997-09       Impact factor: 11.056

6.  Altered lipopolysaccharide characteristic of the I69 phenotype in Haemophilus influenzae results from mutations in a novel gene, isn.

Authors:  A Preston; D Maskell; A Johnson; E R Moxon
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

7.  Molecular cloning and characterization of the nontypeable Haemophilus influenzae 2019 rfaE gene required for lipopolysaccharide biosynthesis.

Authors:  N G Lee; M G Sunshine; M A Apicella
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

8.  Utilizing the O-antigen lipopolysaccharide biosynthesis pathway in Escherichia coli to interrogate the substrate specificities of exogenous glycosyltransferase genes in a combinatorial approach.

Authors:  Eric B Johansen; Francis C Szoka; Anthony Zaleski; Michael A Apicella; Bradford W Gibson
Journal:  Glycobiology       Date:  2010-03-05       Impact factor: 4.313

9.  Generation of lipooligosaccharide mutants of Haemophilus influenzae type b.

Authors:  R McLaughlin; S M Spinola; M A Apicella
Journal:  J Bacteriol       Date:  1992-10       Impact factor: 3.490

10.  Lipooligosaccharides (LOS) of some Haemophilus species mimic human glycosphingolipids, and some LOS are sialylated.

Authors:  R E Mandrell; R McLaughlin; Y Aba Kwaik; A Lesse; R Yamasaki; B Gibson; S M Spinola; M A Apicella
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.